Previous Proposals
2019
- John Kowalski – Characterization of Selective Mechanism-Based Inhibitors of Cytochrome P450 4Z1
- Shelly Gray – Potentially Inappropriate Medication Use and the Risk of Adverse Drug Events in People with Dementia
2018
- Cara McDermott – Medication Patterns of Use, the Potential for De-prescribing, and Oncology Prescriber Attitudes Towards De-prescribing for Older Adults with Multiple Chronic Conditions and Advanced Cancer
- David Newland – Retrospective Analysis of Rabbit Antithymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients
- Laura Hart – Patterns and Predictors of Central Nervous System-Active Medication Use in Community-Dwelling Older Adults after Fall-Related Injury
- Melissa Barker-Haliski – Age-dependent Impact of Alzheimer’s Disease-Associated Mutation in Presenilin 2 on Susceptibility to Chronic Seizures and Acute Pharmacotherapeutic Response
- Sara Shum – Predicting Maternal and Fetal Disposition of Short-Acting Opioids, Hydrocodone and Oxycodone, during Pregnancy
Previous Proposals funded by the Plein Endowed Fund
- Pharm Intervention for Patients with High Drug Usage and Multiple Providers
- Using A New Non-Invasive Magnetometric Method to Measure Effect of Cisapride on Gastric Motility: A Pilot Study
- Establishing a Community Pharmacy Anticoagulation Clinic
- Improving Pharmaceutical Outcomes of Hospice Patients Using a Symptom Management Protocol
- Study of Pharmacists’ Consultations Sought by Residents of Continuing Care Retirement Community
- An Evaluation of a Community Pharmacy Based Pneumococcal and Influenza Vaccination Project
- Pharmacist Dispensing and Patient Education for Over-the-Counter Medicines in a Culturally Diverse Pediatric Clinic
- Improving Pharmaceutical Care of Oncology Patients Through a Computerized Database Management Program
- Evaluation of Retail Pharmacies’ Contribution to Influenza/Pneumococcal Vaccine Coverage Among Elderly Community Residents
- Pharmacist-managed Smoking Cessation
- Improving Pneumococcal Vaccination Rates in Long Term Care Facilities
- Increasing Osteoporosis Awareness and Offering Bone Density Measurements in Community Pharmacies
- An Innovative Pharmacist Designed and Managed Research Service in a Community Health System Setting
- Osteoporosis Screening in an Asian Community
- A Survey of the Pharmacist Prescriptive Authority Protocols in Washington State
- A Pharmacists-Coordinated Program to Improve Outcomes of Coronary Artery Disease Patients through Multiple Risk Factor Modification in a Community Health System Setting
- Effects of St John’s Wort (SJW Hypericum perforatum) on the Oral Pharmacokinetics of Tacrolimus (FK) and Cyclosporine (CsA) in Healthy Volunteers
- Methadone Maintenance in Primary Care and the Role of Clinical Pharmacists in Assessing and Dispensing Methadone for Treatment
- OTC and Herbal Management in the Assisted Living Community
- Quality Improvement through Root Cause Analysis in Independent Community Practice
- Assessing and Dispensing Methadone by Pharmacy for Medical Maintenance Treatment
- A Determination of Attributes of the Successful Pharmacist
- Innovative Approach to Geriatric Diabetes Disease Management
- The Cost-Effectiveness of Gene Expression Profiling in Women with Early Stage Breast Cancer
- Role of Breast Cancer Resistance Protein (BCRP) in the Transport of Anti-Epileptic Drugs (AEDs)
- An Assessment of the Use of NABPLaw Online by Pharmacy Students
- Changes in Lymphocyte P-lycoprotein Activity and Expression During Pregnancy
- Predictors of Psychotropic Use in Medicaid Funded Residential Care Facilities
- The Effect of ST1571 (Gleevec) on Fludarabine Disposition and Cytotoxicity Medication Use and Pharmacy and Nursing Care Provided in Six Seattle-Area Assisted Living Homes
- Evaluating the Role of CYP2J2 in Drug Induced Renal Toxicity
- Longitudinal Examination of the Association of ACE-Inhibitor or Statin Use with Frailty, Walking Speed, and Mobility Disability
- Uptake and Activation of Fludarabine in Natural Killer Cells
Jonathan Watanabe, ‘08, ‘12, PharmD, MS, PhD, BCGP, is a board-certified geriatrics pharmacist, outcomes researcher, and associate professor at the University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Watanabe was the first the UW/Allergan Global Health Economics and Outcomes Research Fellow. His research on the cost of non-optimized therapy, comprehensive medication management and drug prices has been cited in successful state legislative efforts for pharmacist provider status. Dr. Watanabe is an inaugural scholar in the National Academy of Medicine Emerging Leaders in Health and Medicine program.
Shirley is a Seattleite, born and raised. From a young age, she dedicated her life to advocating for women, children, human rights and healthcare. Encouragement from her mother, and her knack for science, led Shirley to Pharmacy school where she thrived. Her career helped so many people, but as the HIV/AIDS epidemic grew, it became a central part of her career. Her outreach efforts, where she went door to door to help people understand the disease, was only part of her contribution to battle the epidemic. She was a founding board member of AIDS Housing of Washington (recently renamed Building Changes) and co-chaired the $8.5 million campaign that built the group’s Bailey-Boushay House in 1992. Her legacy of advocating for women pharmacists lives on with the Herb and Shirley Bridge Endowed Professorship, designed to support women in pharmacy.
Dr. Hall joined the faculty of the School of Pharmacy in 1952, after spending a few years at the Eli Lilly and Co. as a Pharmaceutical Chemist. After returning to the UW, he soon set himself apart from his peers by developing innovative approaches to teaching, particularly in dispensing pharmacy. While at UW Hall developed one of the first models for an externship program, allowing senior pharmacy students to gain theoretical and practical experience in a pharmacy setting for academic credit. Being too ahead of his time, this for credit externship program did not became a formal requirement in the School of Pharmacy’s curriculum until the 1990’s, thanks in large part to Dr. Hall’s vision. Dr. Hall was also awarded the Distinguished Alumnus Award in 1980 to celebrate the impact of his career on the profession of Pharmacy.
After completing his graduate work in California, Sid Nelson returned to the School of Pharmacy to join the faculty in 1977. Progressing through the ranks, he landed his “dream job” as the Dean of the School of Pharmacy in 1995. Under his leadership, the School converted our degree offerings from a B.S. degree to an entry-level Doctor of Pharmacy degree program and added a nontraditional approach that enabled existing pharmacists to obtain the Pharm.D. degree. He also evolved the graduate programs and worked tirelessly to expand the School’s faculty. In 2008, he returned full-time to his research and teaching activities in the School’s Department of Medicinal Chemistry. Sid truly embodies the idea of a legend with his warmth, care and passion for our students and alumni.
Timothy Fuller, ‘69, is an independent pharmacist consultant and founder of Timothy S. Fuller & Associates, Inc. Consulting. He is recognized as the Father of Pharmacist Collaborative Drug Therapy for his extensive and continued research, advocacy, and publication on the subject. In partnership with the WSPA and PATH, Tim recruited 50 pharmacies in Washington to pilot the U.S. movement for pharmacists to prescribe emergency contraceptive pills. Tim is the fourth member of the UW School of Pharmacy B.S. Class of 1969 to receive a PAA Distinguished Alumni Award.